Antinociception by the anti‐oxidized phospholipid antibody E06
- 21 April 2018
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (14) , 2940-2955
Abstract
Background and Purpose: ROS and their downstream molecules such as oxidized phospholipids (OxPL) and 4‐hydroxynonenal activate TRPA1 and TRPV1 (vanilloid 1) cation channels in vivo and in vitro shaping thermal and mechanical hypersensitivity in inflammatory pain. E06/T15 is a monoclonal autoantibody against oxidized phosphatidylcholine (OxPC) used in diagnostics in arteriosclerosis. Recently, we provided evidence that E06 also ameliorates inflammatory pain. Here, we studied E06 for local treatment against hypersensitivity evoked by endogenous and exogenous agonists of TRPA1 or TRPV1 channels.Experimental Approach: We utilized a combination of reflexive and complex behavioural pain measurements, live‐cell calcium imaging and OxPC‐binding assays. The lipid peroxidation metabolite 4‐hydroxynonenal, hydrogen peroxide as a source of ROS, allyl isothiocyanate and capsaicin were used to activate their respective receptors.Key Results: All irritants induced thermal and mechanical hypersensitivity, spontaneous nocifensive and affective‐motivational behaviour, as well as calcium influx in HEKTRPA1‐ or HEKTRPV1‐cells and dorsal root ganglion neurons. E06 prevented prolonged mechanical hypersensitivity induced by all irritants except for H2O2. E06 did not alter immediate irritant‐induced nocifensive or affective motivational behaviour. In vitro, E06 blocked only 4‐hydroxynonenal‐induced calcium influx although this compound did not bind to E06. After 1–3 h, all tested irritants elicited formation of OxPC in paw tissue.Conclusions and Implications: E06 ameliorates not only inflammatory pain but also prolonged hypersensitivity due to formation of OxPC. This supports the view that neutralizing certain OxPL as endogenous activators of TRPA1 or TRPV1 channels may be valuable for pain therapy.Keywords
Funding Information
- The Interdisciplinary Centre for Clinical Research (IZKF) of the Medical Faculty of the University of Wuerzburg, Germany (N-261, Z2-43, Project N-261 Project Z2-43)
- University Hospital of Wuerzburg
This publication has 85 references indexed in Scilit:
- WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPsJournal of Clinical Investigation, 2013
- Transient opening of the perineurial barrier for analgesic drug deliveryProceedings of the National Academy of Sciences, 2012
- Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous systemProceedings of the National Academy of Sciences, 2011
- Oxidative damage in multiple sclerosis lesionsBrain, 2011
- TRPC5 Channel Sensitivities to Antioxidants and Hydroxylated StilbenesJournal of Biological Chemistry, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Short-Term Stimulation of Calcium-Permeable Transient Receptor Potential Canonical 5–Containing Channels by Oxidized PhospholipidsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Roles of transient receptor potential channels in painBrain Research Reviews, 2009
- TRPA1 mediates formalin-induced painProceedings of the National Academy of Sciences, 2007
- 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1Proceedings of the National Academy of Sciences, 2007